From: Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
 |  | Cases (%) | Total | |
---|---|---|---|---|
MPM | Â | Â | Â | |
 | Age | 65.5±9.2 |  | |
 | Gender | Male / Female | 44(72.1)/ 17(27.9) | 61 |
 | Histology | Epithelioid | 43(70.6) |  |
 |  | Sarcomatoid | 8(13.1) |  |
 |  | Biphasic | 6(9.8) |  |
 |  | Desmoplastic | 3(4.9) |  |
 |  | Anaplastic | 1(1.6) |  |
 | Stage | I / II / III / IV | 7(11.5)/ 6(9.8) / 11(18.0) / 37(60.7) |  |
Non-MPM* | Â | Â | Â | |
 | Age | 67.1±10.3 |  | |
 | Gender | Male / Female | 39(86.7) / 6(13.3) | 45 |
 | CT findings | Plaque | 24(53.3) |  |
 |  | Asbestosis | 0(0.0) |  |
 |  | Plaque and asbestosis | 2(4.5) |  |
 |  | None | 19(42.2) |  |